Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain
- PMID: 12944914
- DOI: 10.1038/sj.onc.1206690
Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain
Abstract
Rhabdomyosarcoma (RMS) has deregulated proliferation and is blocked in the differentiation program despite Myf-5, MyoD and myogenin expression. Here we show that ectopic expression of MRF4, which is not subject to an autoregulatory pathway but regulated by the other MRFs protein family, induces growth arrest and terminal differentiation in RD cells. Deletion mapping identified a positive-acting C-terminal domain in MRF4 as the mediator of transcriptional activity, revealing a conserved motif with helix III in MyoD previously found to initiate expression of endogenous skeletal muscle genes. By using chimeric MyoD/MRF4 proteins, we observe that the C-terminal motif of MRF4 rescues MyoD activity in RD cells. Moreover, comparative induction of muscle-specific genes following activation of MyoD, through the expression of a constitutively activated MKK6 either in the absence or presence of MRF4, shows that MyoD and MRF4 can differently regulate muscle genes expression. Together, these results demonstrate that the MRF4 C-terminus functions as specification as well as activation domain in tumor cells. They provide a basis to identify gene products necessary for b-HLH-mediated differentiation versus tumor progression.
Similar articles
-
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.Mol Cancer. 2005 Dec 13;4:41. doi: 10.1186/1476-4598-4-41. Mol Cancer. 2005. PMID: 16351709 Free PMC article.
-
Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.Cell Growth Differ. 1998 Sep;9(9):699-711. Cell Growth Differ. 1998. PMID: 9751114
-
The molecular basis of skeletal muscle differentiation.Semin Diagn Pathol. 1994 Feb;11(1):3-14. Semin Diagn Pathol. 1994. PMID: 8202645 Review.
-
MRF4 can substitute for myogenin during early stages of myogenesis.Dev Dyn. 1997 Jun;209(2):233-41. doi: 10.1002/(SICI)1097-0177(199706)209:2<233::AID-AJA9>3.0.CO;2-J. Dev Dyn. 1997. PMID: 9186058
-
Involvement of cdks and cyclins in muscle differentiation.Eur J Histochem. 2006 Jan-Mar;50(1):19-23. Eur J Histochem. 2006. PMID: 16584981 Review.
Cited by
-
Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery.Exp Biol Med (Maywood). 2018 Jan;243(2):118-128. doi: 10.1177/1535370217749494. Epub 2018 Jan 7. Exp Biol Med (Maywood). 2018. PMID: 29307280 Free PMC article. Review.
-
The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation.Oncogene. 2007 Feb 22;26(8):1122-36. doi: 10.1038/sj.onc.1209891. Epub 2006 Sep 11. Oncogene. 2007. PMID: 16964293 Free PMC article.
-
Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.Sarcoma. 2012;2012:357040. doi: 10.1155/2012/357040. Epub 2012 Feb 21. Sarcoma. 2012. PMID: 22550417 Free PMC article.
-
Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.PLoS One. 2009;4(3):e4973. doi: 10.1371/journal.pone.0004973. Epub 2009 Mar 25. PLoS One. 2009. PMID: 19319192 Free PMC article.
-
Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.Mol Cell Biol. 2013 Feb;33(4):773-84. doi: 10.1128/MCB.00916-12. Epub 2012 Dec 10. Mol Cell Biol. 2013. PMID: 23230269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous